For biotech executives, raising big dollars for big ideas can seem like a full-time job. The most recent fundraising winners in this region have something in common: They spun out of larger, established institutions.
Take Integrated Diagnostics, a Seattle biotech company that announced today it had raised $47.25 million. The funding announcement comes just a week after Seattle-based Juno Therapeutics announced that it had raised $176 million in Series A funding.
“It feels good,” said Albert…
For biotech executives, raising big dollars for big ideas can seem like a full-time job. The most recent fundraising winners in this region have something in common: They spun out of larger, established institutions.
Take Integrated Diagnostics, a Seattle biotech company that announced today it had raised $47.25 million. The funding announcement comes just a week after Seattle-based Juno Therapeutics announced that it had raised $176 million in Series A funding.
“It feels good,” said Albert…